Pharmacia Corp. a future biotech powerhouse? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Pharmacia Corp. a future biotech powerhouse?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jack Hartmann who wrote (19)	7/25/2000 11:21:50 AM
From: Jack Hartmann	Read Replies (1) of 35

Pharmacia (PHA) 56 9/16 +3 9/16: Reports Q2 earnings of $0.47 a share, in line with the First Call consensus of $0.47, vs year-ago earnings of $0.80; revenues rose 15.4% to $5.03 bln from a year-ago of $4.36 bln; ********* $19M in Zyvox sales. The new anti-botic is the drug to watch. Jack

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next